| Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial | Lancet, The | 2016 | 2.3K |
| Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers | Cmaj | 2004 | 614 |
| Resistance exercise in men receiving androgen deprivation therapy for prostate cancer | Journal of Clinical Oncology | 2003 | 601 |
| Wnt signaling pathway in non-small cell lung cancer | Journal of the National Cancer Institute | 2014 | 405 |
| Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial | Lancet Oncology, The | 2015 | 314 |
| Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial | Lancet Oncology, The | 2017 | 253 |
| Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review | Lancet Oncology, The | 2011 | 240 |
| Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway | Cancer Research | 2006 | 211 |
| Screening for Occult Cancer in Unprovoked Venous Thromboembolism | New England Journal of Medicine | 2015 | 189 |
| Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial | Lancet Oncology, The | 2019 | 164 |
| The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials | Journal of Thrombosis and Haemostasis | 2007 | 159 |
| Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins | Endocrinology | 2001 | 157 |
| Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis | JAMA Oncology | 2016 | 139 |
| Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review | Critical Reviews in Oncology/Hematology | 2006 | 137 |
| Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function | International Journal of Cancer | 2008 | 133 |
| CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials | Annals of Oncology | 2018 | 132 |
| p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells | Cancer Research | 2003 | 130 |
| Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies | Cancer Treatment Reviews | 2012 | 128 |
| Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial | Annals of Oncology | 2011 | 128 |
| A survey of practice in management of malignant ascites | Journal of Pain and Symptom Management | 1998 | 118 |
| Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway | Drug Resistance Updates | 2002 | 117 |
| Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome | Acta Neuropathologica | 2017 | 114 |
| Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials | Cmaj | 2007 | 114 |
| Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages | Proceedings of the National Academy of Sciences of the United States of America | 2014 | 111 |
| Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability | New England Journal of Medicine | 2019 | 110 |
